Abstract
Accumulating evidence indicates that peripheral nerve injury (PNI) activates spinal microglia that are necessary for neuropathic pain. Recent studies using bone marrow (BM) chimeric mice have reported that after PNI, circulating BM-derived cells infiltrate into the spinal cord and differentiate into microglia-like cells. This raises the possibility that the population of spinal microglia after PNI may be heterogeneous. However, the infiltration of BM cells in the spinal cord remains controversial because of experimental adverse effects of strong irradiation used for generating BM chimeric mice. In this study, we evaluated the PNI-induced spinal infiltration of BM-derived cells not only by irradiation-induced myeloablation with various conditioning regimens, but also by parabiosis and mice with genetically labelled microglia, models without irradiation and BM transplantation. Results obtained from these independent approaches provide compelling evidence indicating little contribution of circulating BM-derived cells to the population of spinal microglia after PNI.
Similar content being viewed by others
Introduction
Neuropathic pain occurring after peripheral nerve injury (PNI) is a highly debilitating chronic pain state and is often resistant to all treatments currently available, including non-steroidal anti-inflammatory drugs and opioids1,2. Therefore, unravelling the molecular and cellular mechanisms for the development and maintenance of neuropathic pain is necessary for the discovery of new treatments for neuropathic pain. A growing body of evidence from diverse animal models of neuropathic pain indicates that spinal cord microglia play a pivotal role in the development and maintenance of PNI-induced pain hypersensitivity2,3,4,5,6,7,8. Thus, microglia have received much attention as key players for discovering new mechanisms of neuropathic pain and as potential therapeutic targets7,9,10,11.
Microglia are known as tissue-resident macrophages in the central nervous system (CNS) and constitute 5–20% of the total cells in the adult CNS12,13,14. Recent evidence indicates that the origin of microglia are primitive macrophages in the yolk sac11,15,16. Fate mapping studies have revealed that microglia arise from early yolk sac-derived precursors that leave the yolk sac, migrating to the neuroectoderm via the primitive bloodstream17. These precursors have erythromyeloid potential18. Interestingly, microglial generation is independent of the transcription factor Myb19, which is essential for bone marrow (BM)-derived macrophages20,21. Therefore, it is assumed that microglia might remain throughout life and be maintained by self-renewal in the healthy adult CNS with little contribution from BM-derived monocytes/macrophages22.
Under pathological conditions, microglia become activated and more numerous (referred to as microgliosis). Following PNI, spinal microglia are positive to proliferation markers8,23,24,25,26,27. The proliferation activity of microglia peaks around 2 days after PNI and then declines to basal levels8,23,25,27, which results in an increase in their number by 2- to 4-fold3,28,29,30. These findings have suggested an acute, local expansion of spinal microglia after PNI. However, it has been reported that a considerable percentage (about 30–40%) of spinal microglia after PNI might be BM-derived cells that infiltrate into the spinal dorsal horn parenchyma presumably through peripheral blood circulation31,32,33,34. Interestingly, these infiltrated BM-derived cells have proliferative activity following PNI, express ionized calcium-binding adapter molecule-1 (Iba1, a marker of microglia/macrophages) and show a microglia-like morphology31. Moreover, recent transcriptome studies have shown that resident microglia have a distinct gene expression profile as compared with circulating monocytes or macrophages derived from BM35,36,37. Thus, these findings raise the possibility that the population of spinal cord microglia after PNI may be phenotypically and functionally heterogeneous. This is intriguing in terms of advancing our understanding on the mechanisms involved in neuropathic pain and also their clinical implications. However, one limitation of these studies is that all were investigated in chimeric mice receiving lethal whole-body irradiation with a high dose coupled with BM transplantation. This strong irradiation has been reported to produce multiple toxic side effects including an induction of chemoattractants and a disruption of the blood brain barrier (BBB)38,39,40,41 which might allow the infiltration of circulating blood cells into the spinal cord. Thus, the extent at which BM-derived monocytes/macrophages recruit in the spinal cord after PNI remains an important unresolved question.
In this study, we evaluated the infiltration of BM-derived cells into the spinal cord after PNI using chimeric mice generated using two different approaches: one was myeloablation by whole-body irradiation with various conditioning regimens to reduce undesired side effects and the other was parabiosis in which two mice were surgically joined, a model without irradiation and transplantation. We also used Cx3cr1GFP/+ mice in which all microglia are visualised by replacing the Cx3cr1 gene with the Egfp gene42. By using Cx3cr1GFP/+ mice, microglia and peripheral monocytes/macrophages are able to be distinguished by the level of GFP expression43,44. Our results all show that BM-derived cells do not contribute to the population of spinal microglia after PNI. We propose that PNI-induced spinal microgliosis may not be a consequence of recruitment of BM-derived cells.
Results
To evaluate the infiltration of BM-derived cells into the spinal cord after PNI, we first used BM chimeric mice generated by transplantation of BM cells from transgenic mice ubiquitously expressing green fluorescent protein (GFP) into lethally γ-irradiated adult C57BL/6 mice (single dose of 10 Gy). After 4 weeks, we counted the numbers of GFP+ cells in peripheral blood by flow cytometry and confirmed efficient chimerism as demonstrated by the large proportions of circulating blood leukocytes expressing GFP (97.7%). At 8 weeks, the BM chimeric mice were subjected to PNI and 2 weeks later the recruitment of GFP+ BM-derived cells to the spinal dorsal horn was evaluated immunohistochemically, according to previous studies showing that GFP+ Iba1+ BM-derived cells in the spinal cord are observed 2 weeks after PNI31,32,33,34. We observed many GFP+ cells in the spinal cord ipsilateral to the PNI compared with the contralateral side where few GFP+ cells were present (Fig. 1a). GFP+ cells were immunolabelled with Iba1 and displayed a ramified morphology (Fig. 1b). Among BM-derived GFP+ cells in the dorsal horn (452 cells from 5 sections), the percentage of Iba1+ cells was 83.0% (375 cells) and in this population, ramified morphology was 94.1%. There were also some rod-shaped GFP+ cells (9.1% per total GFP+ cells) along the vasculature that stained positive for the marker of endothelial cells CD31 (Fig. 1c) and round-shaped cells (4.2% per total GFP+ cells) co-labelled with the marker of T cells CD3 (Fig. 1d). These results are comparable to data reported previously31.
Splitting irradiation in lower doses results in milder toxicity than a single strong dose41. Thus, C57BL/6 mice were subjected to split-dose irradiation [two doses of 5 Gy (5 Gy × 2), 3-h interval: total 10 Gy]. We confirmed efficient reconstitution of donor GFP+ cells in the blood of split-dose irradiated mice (97.8%), which was identical to lethal single-dose irradiated mice described above. Surprisingly, despite clear reactive microgliosis by PNI (Fig. 1e), we detected substantially less infiltrated GFP+ BM-derived cells into the spinal dorsal horn after PNI (Fig. 1e). To quantitatively examine PNI-induced spinal infiltration of BM-derived cells, the number of GFP+ cells was assessed by flow-cytometry. Microglia were detected by immunostaining with CD11b, a marker of microglia, in the spinal cord and brain. Indeed, by using Cx3cr1GFP/+ mice in which all microglia express GFP42,45, we confirmed by flow-cytometry that almost all CD11b+ cells in the spinal cord are positive for GFP (99.8%). In irradiated BM chimeric mice (10 Gy × 1) with PNI, the number of CD11b-gated GFP+ cells was increased in the ipsilateral spinal cord, but in split-dose irradiated mice (5 Gy × 2), the cell number dramatically decreased (Fig. 2a,b). We also examined the number of CD11b+ GFP+ cells in the spinal cord after PNI using BM-chimeric mice with various irradiation doses. We found little contribution from BM-derived cells in the spinal cord after PNI (Fig. 2a,b). However, the percentage of GFP+ cells in circulating blood leukocytes was almost identical among the groups with 7 Gy × 1 (95.4%) and 3.5 Gy × 2 (93.7%) (Fig. 2b). Furthermore, PNI-induced microgliosis was similarly induced in the spinal cord: the increase in total CD11b+ cells in the ipsilateral spinal cord was on average 2.6-fold (5 Gy × 1), 2.8-fold (3.5 Gy × 2), 2.6-fold (7.5 Gy × 1) and 2.6-fold (5 Gy × 2) over the contralateral side (Fig. 2c). In the group with 10 Gy × 1, the increase in total CD11b+ cells was slightly less (2.2-fold), which may be due to a toxic effect of strong irradiation. In addition, we examined the different time points after PNI (day 0, 3, 14, 28 and 56). The number of CD11b-gated GFP+ BM-derived cells in the spinal cord was also low at all time-points tested (Fig. 2d). These results showed that the number of CD11b+ GFP+ cells in the spinal cord of irradiated mice (10 Gy × 1) is exceptionally high and that there is no correlation between peripheral blood reconstitution and GFP+ BM-derived cell infiltration into the spinal cord.
To further examine the contribution of BM-derived cells to the population of spinal microglia after PNI, we used mouse parabiosis, in which parabionts (C57BL/6 mice) had been surgically joined with GFP mice, which in turn shares circulating blood between the two mice. As reported previously46, 2 weeks after parabiosis, parabionts had an average of 43.4±1.5% GFP+ cells in circulating blood leukocytes (n = 5). The parabionts were subjected to unilateral PNI 4 weeks after establishment of parabiosis. Two weeks later, we assessed the presence of GFP+ BM-derived cells in the spinal cord. Flow cytometry revealed that CD11b-gated GFP+ cells were almost absent in the spinal dorsal horn of parabionts (Fig. 3a,b), while the PNI-induced microgliosis in the dorsal horn was clearly induced (Fig. 3a,b). The lack of CD11b+ GFP+ cells and the presence of PNI-induced microgliosis was confirmed by immunohistochemical analyses (Fig. 3c). In addition, CD11bneg CD45high GFP+ cells (presumably T-lymphocytes) in the spinal cord was observed after PNI (14.6 ± 1.2% per total CD11bneg CD45high cells), indicating that all types of cells derived from BM do not necessarily infiltrate into the spinal cord after PNI. In the dorsal root ganglia (DRG), GFP+ cells were readily observed in the ipsilateral side (Fig. 3d), which is consistent with evidence indicating that a population of macrophages in the DRG are derived from BM cells47,48. Our data using parabiotic mice provides evidence that circulating peripheral blood cells do not contribute to the spinal microglia population.
Resident microglia and circulating peripheral monocytes can be distinguished by the expression of the chemokine receptor CX3CR1 because microglia highly express this receptor43,44. We thus used Cx3cr1GFP/+ mice as a model without irradiation chimerism or parabiosis surgery. Using flow cytometry, a single population of GFPhigh cells (resident microglia) in the spinal cord in the contralateral side were detected (Fig. 4a). After PNI, the number of spinal GFPhigh microglia increased (Fig. 4b), but the percentages of GFPhigh and GFPlow or negative microglia in the ipsilateral spinal cord were almost identical to that in the contralateral side [GFPhigh: ipsilateral 99.7% and contralateral 99.6% (Fig. 4c); GFPlow or negative: ipsilateral 0.3% and contralateral 0.4%]. Thus, these results suggest that circulating peripheral monocytes do not participate in the population of spinal microglia after PNI.
Discussion
Microgliosis in the spinal cord induced by PNI has been assumed to be associated with a local expansion of resident microglia and/or with the recruitment of BM-derived cells from the bloodstream. Previous investigations in BM chimeric mice with irradiation at 10 Gy, a dose that is used for achieving full myeloablation41, showed infiltration of BM-derived cells into the spinal cord31,32,33,34. Consistent with these studies, we reproduced the spinal infiltration of GFP+ BM cells in irradiated mice (single dose of 10 Gy) and these GFP+ cells differentiated into microglia-like cells. While transplantation of BM cells to irradiated recipients (10 Gy) leads to high chimerism in the blood, it has been shown that such a high dose of whole-body irradiation induces inflammatory mediators and obvious BBB changes38,39,40,41. In this study, splitting irradiation using repeated lower doses, which results in milder toxicity than a single strong dose41, revealed that exposing mice to low doses of irradiation (5 Gy × 2) dramatically reduced the infiltration of CD11b+ BM-derived cells in the spinal cord compared with mice exposed to a single dose of 10 Gy, even though blood chimerism in both groups was almost identical (>97%). The marked reduction in spinal infiltration of CD11b+ GFP+ BM-derived cells was consistently observed in other groups with three different conditioning regimens. In these groups, the number of CD11b+ GFP+ cells was slightly increased in the spinal cord after PNI, which may be due to undesired side effects at lower doses41. Considering that all groups of BM chimeric mice induced PNI-induced spinal microgliosis, our findings suggest that the spinal recruitment of BM-derived cells after PNI, which has been reported previously, may be an experimental artefact. The artefact possibly results from irradiation that might cause BBB disruptions and upregulation of chemokines and adhesion molecules, which leads to recruitment of cells38,39,40,41. To investigate the differential effect of the various radiation dosing regimens on blood-spinal cord-barrier (BSCB) permeability after PNI will require further investigation.
Our study using BM chimeric mice indicates few BM-derived CD11b+ GFP+ cells recruited to the spinal cord after PNI (although one limitation was to use the contralateral, but not sham-operated, spinal cord as controls). This is strongly supported by our further findings using the parabiosis model showing that in the absence of two experimental manipulations, irradiation and BM transplantation, there is no evidence of participation of BM cells to the population of spinal microglia after PNI. One technical limitation of parabiosis is the relatively lower frequency of blood chimerism than irradiated mice with BM transplantation. However, the lack of CD11b+ GFP+ cell recruitment seems to be selective to this cell type and to the spinal cord, as GFP+ cells in the DRG (which are presumably macrophages that are of haematogenous origin47,48) and CD11bneg CD45high GFP+ cells in the spinal cord were all detected after PNI. These data exclude the possibility that the little contribution of BM cells to spinal microglia populations is simply due to the level of circulating blood chimerism. From these results, we conclude that few BM-derived cells infiltrate into the spinal cord parenchyma after PNI and propose that microgliosis might be a consequence of a local expansion of spinal-resident microglia. This is supported by our data using Cx3cr1GFP/+ mice, a genetic approach without irradiation chimerism or parabiosis. Thus, our findings should prompt a careful reinterpretation of the previous literature describing the recruitment of BM-derived cells to the spinal cord after PNI and also using BM chimeric mice generated by a single high dose of whole-body irradiation.
Of course, all BM-derived cells do not necessarily infiltrate into the spinal cord after PNI. Indeed, we detected GFP+ cells with CD11bneg CD45high, a profile that corresponds to lymphocytes including T cells. The PNI-induced recruitment of T cells in the spinal cord has been reported previously49,50,51. The mechanism for the infiltration of this cell-type after PNI remains unclear, but the PNI-induced expression of chemokines and dysfunction of BSCB may be involved33,52,53. Nevertheless, considering the limited number of CD11b+ BM-derived monocytes/macrophages in the ipsilateral spinal cord, such changes may not be sufficient for spinal infiltration of this cell type.
In the contralateral side of the spinal cord in irradiated mice (single dose of 10 Gy), the number of microglia was markedly decreased. The decrease appeared to occur in an irradiation dose-dependent manner, assuming the involvement of toxic inflammatory effects by the strong irradiation. Alternatively, given that resident microglia in the spinal cord are maintained by self-renewal22,54, the relatively high dose of irradiation may disrupt the proliferative capacity of resident microglia in the spinal cord54.
In conclusion, by using three different approaches, we provide evidence indicating little contribution of BM-derived cells in the population of spinal microglia after PNI. Thus, PNI-induced spinal microgliosis is not a consequence of infiltration of BM-derived monocytes/macrophages, but may rather be associated with a local expansion of resident microglia due to their proliferation activity in response to PNI8,23,24,25,26,27.
Methods
Animals
C57BL/6 (male and female), C57BL/6-Tg(CAG-EGFP) (male and female, Japan SLC) and B6.129P-Cx3cr1tm1Litt/J mice (male, Jackson Laboratory) were used. All mice were aged 4–10 weeks at the start of each experiment and were housed in groups of two or three per cage at a temperature of 22 ± 1 °C with a 12-hour light-dark cycle and were fed food and water ad libitum. All animal experiments were conducted according to the national and international guidelines contained in the ‘Act on Welfare and Management of Animals’ (Ministry of Environment of Japan) and ‘Regulation of Laboratory Animals’ (Kyushu University) and under the protocols approved by the Institutional Animal Care and Use committee review panels at Kyushu University.
Generation of bone marrow chimera
Recipient C57BL/6 mice (male) at age 4–5 weeks were irradiated with various doses (1 dose of 5, 7 or 10 Gy; 2 doses of 3.5 or 5 Gy, 3-h interval) of γ-irradiation (Gammacell 40 Exactor) for ablation of endogenous BM cells. For BM transplantation, BM cells were isolated from adult CAG-EGFP mice (male, donor) by flushing the femurs and tibias using a 25G needle with Dulbecco’s modified Eagle medium (DMEM; Invitrogen). After resuspension, BM cells were centrifuged (300 × g, 5 min, 4 °C). After resuspension with ice-cold DMEM, BM cells were filtered through a 35-μm filter. Irradiated recipient C57BL/6 mice were anesthetised with isoflurane [2% (v/v)] and injected intravenously with 0.5–1.0 × 107 donor BM cells (in 100 μL per recipient) through the retro-orbital sinus within 1 or 2 h after final irradiation. Four weeks after BM transplantation, a small amount of blood was collected through the retro-orbital sinus using a heparinised microhematocrit capillary (Fisher Scientific). The erythrocytes were lysed with a lysing buffer (BD Pharm LyseTM, BD Bioscience) and after centrifugation (400 × g, 5 min, 4 °C), the leukocytes were washed in Hanks’ balanced salt solution (HBSS) including 2% (v/v) fetal bovine serum (FBS). Blood leukocytes were analysed by flow cytometry (FACSVerse) for GFP to examine the degree of chimerism of bone marrow cells. Three months after BM transplantation, BM chimeric mice were subjected to PNI.
Peripheral nerve injury
We used the spinal nerve injury model with some modifications as described previously55. Under isoflurane [2% (v/v)] anaesthesia, a small incision at L3–S1 was made. Paraspinal muscle and fat were removed from the L5 traverse process and the part of this traverse process was removed to expose the parallel-lying L3 and L4 spinal nerves and then the L4 nerve was carefully isolated and cut. The wound and the surrounding skin were sutured with 5-0 silk and closed with staples.
Immunohistochemistry
Mice were deeply anaesthetised by i.p. injection of pentobarbital and perfused transcardially with phosphate buffered saline (PBS), followed by ice-cold 4% (w/v) paraformaldehyde/PBS. The L4 segments of the spinal cord, or the L4 DRG were removed, postfixed in the same fixative for 3 h at 4 °C and placed in 30% (w/v) sucrose solution for 24 h at 4 °C. Transverse L4 spinal cord sections (30 μm) and L4 DRG sections (15 μm) were incubated in blocking solution [3% (v/v) normal goat serum] for 2 h at room temperature and then incubated for 48 h at 4 °C with primary antibodies: rabbit polyclonal anti-Iba1 (1:5000, Wako) and rat monoclonal anti-CD11b (1:1000, Serotec), rat monoclonal anti-CD31 (1:200, BD Pharmingen) and hamster monoclonal anti-CD3 (1:100, eBioscience). Following incubation, tissue sections were washed and incubated for 3 h at room temperature in secondary antibody solution (Alexa Fluor 546 and Alexa Fluor 405, 1:1000, Molecular Probes, OR, USA). The tissue sections were washed, slide-mounted and subsequently coverslipped with Vectashield hardmount (Vector Laboratories). Three to five sections from the L4 spinal cord and DRG of each mouse were randomly selected and analysed using an LSM700 Imaging System (Carl Zeiss).
Flow cytometry
Mice were deeply anaesthetised by i.p. injection of pentobarbital and perfused transcardially with PBS to remove circulating blood from the vasculature. The spinal cord was rapidly and carefully removed from the vertebral column and placed into ice-cold HBSS. The 3rd and 4th lumbar segments (2 mm long) of the spinal cord ipsilateral and contralateral to PNI were separated. Unilateral spinal tissue pieces were treated with pre-warmed 0.8-mL enzymatic solution [0.2 U/mL Collagenase D (Roche) and 4.3 U/mL of Dispase (GIBCO)] in HBSS-FBS for 30 min at 37 °C. The tissues were homogenised by passing through a 23G needle attached with a 1-mL syringe and were further incubated for 15 min at 37 °C. After that, the tissues were homogenised by passing twice through a 26G needle and the enzymatic reaction was stopped by adding EDTA (0.5 M). Further processing was performed at 4 °C. After centrifugation (400 × g, 5 min, 4 °C), the pellets were resuspended in ice-cold HBSS-FBS. The resultant cell suspension [350 μL of the total suspension (500 μL)] was used for flow cytometry. The cell suspension was blocked by incubating with Fc Block (BD Pharmingen, 5 min, 4 °C) and immunostained with CD11b-A647 (BD Pharmingen, 1:10000, 30 min, 4 °C) and CD45-PerCP/Cy5.5 (BD Pharmingen, 1:1000, 30 min, 4 °C) in the dark. After washing, the pellet was resuspended in ice-cold HBSS-FBS and filtered through a 35-μm nylon cell strainer (BD Biosciences, San Jose, CA) to isolate tissue debris from the cell suspension. The total number of microglia in the L3/4 spinal cord was analysed using a FACSVerse flow cytometer (BD Bioscience) and FlowJo software (TreeStar).
Parabiosis
Parabiotic pairs of female mice (CAG-EGFP and C57BL/6) were age-matched (6 to 7 weeks old) and housed together for 2 weeks before surgery. They were given a medicated Sulfa-Trim diet containing 0.124% (w/v) sulfamethoxazole and 0.025% (w/v) trimethoprim (TestDiet) 2 weeks prior to operation. Under isoflurane [2% (v/v)] anaesthesia, a mirror-image incision from elbow to knee along the flank of each mouse was made and the subcutaneous fascia was bluntly dissected. Ligaments at the elbow and knee in each pair of mice were sutured together with 5-0 silk. The skin incisions were then closed with staples. Animals recovered in a heated cage. After the operation, each parabiont was subcutaneously injected with 1 mL of warm saline twice daily for 48 h. Two weeks after the operation, the medicated Sulfa-Trim diet was exchanged with a normal diet. One month after the operation, blood chimerism was analysed by flow cytometry. After that, parabionts (C57BL/6) were subjected to PNI and, 2 weeks later, the number of GFP+ cells in the spinal cord and DRG was analysed by flow cytometry and immunohistochemistry.
Statistical analysis
Statistical significance of differences was determined using two-way ANOVA with post hoc Bonferroni test (Fig. 2b,c), one-way ANOVA with post hoc Dunnett’s multiple comparison test (Fig. 2b,c) or Paired Student’s t test (Figs 3b and 4b,c) using GraphPad Prism 4 software. Differences were considered significant at P < 0.05.
Additional Information
How to cite this article: Tashima, R. et al. Bone marrow-derived cells in the population of spinal microglia after peripheral nerve injury. Sci. Rep. 6, 23701; doi: 10.1038/srep23701 (2016).
References
Baron, R. Mechanisms of disease: neuropathic pain–a clinical perspective. Nat Clin Pract Neurol 2, 95–106 (2006).
von Hehn, C. A., Baron, R. & Woolf, C. J. Deconstructing the neuropathic pain phenotype to reveal neural mechanisms. Neuron 73, 638–652 (2012).
Tsuda, M. et al. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 424, 778–783 (2003).
Masuda, T. et al. IRF8 is a critical transcription factor for transforming microglia into a reactive phenotype. Cell Rep 1, 334–340 (2012).
Tsuda, M., Masuda, T., Tozaki-Saitoh, H. & Inoue, K. Microglial regulation of neuropathic pain. J Pharmacol Sci 121, 89–94 (2013).
Masuda, T. et al. Transcription factor IRF5 drives P2X4R+-reactive microglia gating neuropathic pain. Nat Commun 5, 3771 (2014).
Beggs, S., Trang, T. & Salter, M. W. P2X4R+ microglia drive neuropathic pain. Nat Neurosci 15, 1068–1073 (2012).
Guan, Z. et al. Injured sensory neuron-derived CSF1 induces microglial proliferation and DAP12-dependent pain. Nat Neurosci 19, 94–101 (2016).
Tsuda, M., Inoue, K. & Salter, M. W. Neuropathic pain and spinal microglia: a big problem from molecules in “small” glia. Trends Neurosci 28, 101–107 (2005).
Ji, R. R., Xu, Z. Z. & Gao, Y. J. Emerging targets in neuroinflammation-driven chronic pain. Nat Rev Drug Discov 13, 533–548 (2014).
Biber, K., Moller, T., Boddeke, E. & Prinz, M. Central nervous system myeloid cells as drug targets: current status and translational challenges. Nat Rev Drug Discov (2015).
Saijo, K. & Glass, C. K. Microglial cell origin and phenotypes in health and disease. Nat Rev Immunol 11, 775–787 (2011).
Aguzzi, A., Barres, B. A. & Bennett, M. L. Microglia: scapegoat, saboteur, or something else? Science 339, 156–161 (2013).
Kettenmann, H., Kirchhoff, F. & Verkhratsky, A. Microglia: new roles for the synaptic stripper. Neuron 77, 10–18 (2013).
Prinz, M. & Priller, J. Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease. Nat Rev Neurosci 15, 300–312 (2014).
Salter, M. W. & Beggs, S. Sublime microglia: expanding roles for the guardians of the CNS. Cell 158, 15–24 (2014).
Ginhoux, F. et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330, 841–845 (2010).
Kierdorf, K. et al. Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways. Nat Neurosci 16, 273–280 (2013).
Schulz, C. et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 336, 86–90 (2012).
Yona, S. et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity 38, 79–91 (2013).
Hashimoto, D. et al. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity 38, 792–804 (2013).
Ajami, B., Bennett, J. L., Krieger, C., Tetzlaff, W. & Rossi, F. M. Local self-renewal can sustain CNS microglia maintenance and function throughout adult life. Nat Neurosci 10, 1538–1543 (2007).
Gehrmann, J. & Banati, R. B. Microglial turnover in the injured CNS: activated microglia undergo delayed DNA fragmentation following peripheral nerve injury. J Neuropathol Exp Neurol 54, 680–688 (1995).
Narita, M. et al. Direct evidence for spinal cord microglia in the development of a neuropathic pain-like state in mice. J Neurochem 97, 1337–1348 (2006).
Echeverry, S., Shi, X. Q. & Zhang, J. Characterization of cell proliferation in rat spinal cord following peripheral nerve injury and the relationship with neuropathic pain. Pain 135, 37–47 (2008).
Suter, M. R., Wen, Y. R., Decosterd, I. & Ji, R. R. Do glial cells control pain? Neuron Glia Biol 3, 255–268 (2007).
Tsuda, M. et al. JAK-STAT3 pathway regulates spinal astrocyte proliferation and neuropathic pain maintenance in rats. Brain 134, 1127–1139 (2011).
Beggs, S. & Salter, M. W. Stereological and somatotopic analysis of the spinal microglial response to peripheral nerve injury. Brain Behav Immun 21, 624–633 (2007).
Clark, A. K. et al. Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain. Proc Natl Acad Sci USA 104, 10655–10660 (2007).
Thacker, M. A. et al. CCL2 is a key mediator of microglia activation in neuropathic pain states. Eur J Pain 13, 263–272 (2009).
Zhang, J. et al. Expression of CCR2 in both resident and bone marrow-derived microglia plays a critical role in neuropathic pain. J Neurosci 27, 12396–12406 (2007).
Padi, S. S. et al. Attenuation of rodent neuropathic pain by an orally active peptide, RAP-103, which potently blocks CCR2- and CCR5-mediated monocyte chemotaxis and inflammation. Pain 153, 95–106 (2012).
Echeverry, S., Shi, X. Q., Rivest, S. & Zhang, J. Peripheral Nerve Injury Alters Blood-Spinal Cord Barrier Functional and Molecular Integrity through a Selective Inflammatory Pathway. J Neurosci 31, 10819–10828 (2011).
Isami, K. et al. Involvement of TRPM2 in peripheral nerve injury-induced infiltration of peripheral immune cells into the spinal cord in mouse neuropathic pain model. PLoS One 8, e66410 (2013).
Gautier, E. L. et al. Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nat Immunol 13, 1118–1128 (2012).
Butovsky, O. et al. Identification of a unique TGF-beta-dependent molecular and functional signature in microglia. Nat Neurosci 17, 131–143 (2014).
Gosselin, D. et al. Environment drives selection and function of enhancers controlling tissue-specific macrophage identities. Cell 159, 1327–1340 (2014).
Hwang, S. Y. et al. Ionizing radiation induces astrocyte gliosis through microglia activation. Neurobiol Dis 21, 457–467 (2006).
Mildner, A. et al. Distinct and non-redundant roles of microglia and myeloid subsets in mouse models of Alzheimer’s disease. Journal of Neuroscience 31, 11159–11171 (2011).
Kierdorf, K., Katzmarski, N., Haas, C. A. & Prinz, M. Bone marrow cell recruitment to the brain in the absence of irradiation or parabiosis bias. PLoS One 8, e58544 (2013).
Larochelle, A., Bellavance, M. A., Michaud, J. P. & Rivest, S. Bone marrow-derived macrophages and the CNS: An update on the use of experimental chimeric mouse models and bone marrow transplantation in neurological disorders. Biochim Biophys Acta (2015).
Jung, S. et al. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol Cell Biol 20, 4106–4114 (2000).
Saederup, N. et al. Selective chemokine receptor usage by central nervous system myeloid cells in CCR2-red fluorescent protein knock-in mice. PLoS One 5, e13693 (2010).
Yamasaki, R. et al. Differential roles of microglia and monocytes in the inflamed central nervous system. J Exp Med 211, 1533–1549 (2014).
Davalos, D. et al. ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 8, 752–758 (2005).
Wright, D. E., Wagers, A. J., Gulati, A. P., Johnson, F. L. & Weissman, I. L. Physiological migration of hematopoietic stem and progenitor cells. Science 294, 1933–1936 (2001).
Vass, K., Hickey, W. F., Schmidt, R. E. & Lassmann, H. Bone marrow-derived elements in the peripheral nervous system. An immunohistochemical and ultrastructural investigation in chimeric rats. Lab Invest 69, 275–282 (1993).
Muller, M., Leonhard, C., Krauthausen, M., Wacker, K. & Kiefer, R. On the longevity of resident endoneurial macrophages in the peripheral nervous system: a study of physiological macrophage turnover in bone marrow chimeric mice. J Peripher Nerv Syst 15, 357–365 (2010).
Cao, L. & DeLeo, J. A. CNS-infiltrating CD4+ T lymphocytes contribute to murine spinal nerve transection-induced neuropathic pain. Eur J Immunol 38, 448–458 (2008).
Costigan, M. et al. T-cell infiltration and signaling in the adult dorsal spinal cord is a major contributor to neuropathic pain-like hypersensitivity. J Neurosci 29, 14415–14422 (2009).
Leger, T., Grist, J., D’Acquisto, F., Clark, A. K. & Malcangio, M. Glatiramer acetate attenuates neuropathic allodynia through modulation of adaptive immune cells. J Neuroimmunol 234, 19–26 (2011).
Costigan, M., Scholz, J. & Woolf, C. J. Neuropathic pain: a maladaptive response of the nervous system to damage. Annu Rev Neurosci 32, 1–32 (2009).
Beggs, S., Liu, X. J., Kwan, C. & Salter, M. W. Peripheral nerve injury and TRPV1-expressing primary afferent C-fibers cause opening of the blood-brain barrier. Mol Pain 6, 74 (2010).
Bruttger, J. et al. Genetic Cell Ablation Reveals Clusters of Local Self-Renewing Microglia in the Mammalian Central Nervous System. Immunity 43, 92–106 (2015).
Kohro, Y. et al. A new minimally-invasive method for microinjection into the mouse spinal dorsal horn. Sci Rep 5, 14306 (2015).
Acknowledgements
We thank Prof. Hiromitsu Hara (Kagoshima University) for assisting BM chimera experiments. This work was supported by JSPS KAKENHI Grant Numbers 15H02522 (MT), 25117013 (KI, HTS), the Kyushu University Progress 100 (MT), the Research Project on Elucidation of Chronic Pain from Japan Agency for Medical Research and Development (MT) and the Toray Science Foundation (MT).
Author information
Authors and Affiliations
Contributions
R.T., S.M. and D.T. performed BM chimera experiments and analysed the data. M.S.-H., Y.K., T.Y. and H.T.-S. assisted with experiments. K.I. provided advice and data interpretation. M.T. conceived the project, designed and performed the experiments and wrote the manuscript.
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
About this article
Cite this article
Tashima, R., Mikuriya, S., Tomiyama, D. et al. Bone marrow-derived cells in the population of spinal microglia after peripheral nerve injury. Sci Rep 6, 23701 (2016). https://doi.org/10.1038/srep23701
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/srep23701
This article is cited by
-
Central IRF4/5 Signaling Are Critical for Microglial Activation and Impact on Stroke Outcomes
Translational Stroke Research (2023)
-
Neuroplasticity related to chronic pain and its modulation by microglia
Inflammation and Regeneration (2022)
-
Decreased PPARgamma in the trigeminal spinal subnucleus caudalis due to neonatal injury contributes to incision-induced mechanical allodynia in female rats
Scientific Reports (2022)
-
Tissue-resident M2 macrophages directly contact primary sensory neurons in the sensory ganglia after nerve injury
Journal of Neuroinflammation (2021)
-
MHCII-restricted T helper cells: an emerging trigger for chronic tactile allodynia after nerve injuries
Journal of Neuroinflammation (2020)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.